Wednesday, 10 August 2022

USFDA approves Amantadine Hydrochloride by Strides Shasun

12 June 2017 | News

These capsules are indicated for the treatment of Parkinson’s disease and in the treatment of Shingles (Herpes Zoster) to reduce pain

Amantadine Hydrochloride Capsules USP, 100 mg by pharma company Strides Shasun has been approved by United States Food & Drug Administration (USFDA).

These capsules are indicated for the treatment of Parkinson’s disease and in the treatment of Shingles (Herpes Zoster) to reduce pain.

According to IMS data, the US market for this product is approximately USD 25 Million with three generic players. The product will be launched immediately.

Strides Shasun has four business verticals, viz., Regulated Markets, Emerging Markets, Institutional Business and Active Pharmaceutical Ingredients.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account